Developer docs
API playgroundTry for free, no card

Search company profiles

MSA Partners

Full company profile

uuid0023d6g

Namestring
MSA Partners
Legal namestring
MSAPR Partners
Websiteurl
msapr.com
Company typeenum
Private
Founded yearint
1983
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical market intelligence, biotech industry research, cross-border consulting, Japanese business consulting, regulatory intelligence services
Industry1 code
PRIMARYMPAAALAA
B2B / Industrial Market Research
NAICS code2 codes
  • Marketing Research and Public Opinion Polling541910
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Pharmaceutical Market Intelligence & Cross-Border Business Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Beikoku Seiyaku Gyokai Shuho (US Pharmaceutical Industry Weekly Report)
TypeSubscription Recurring
Description

Weekly publication covering regulatory and industry developments in the US pharmaceutical market, published in Japanese. Delivered as PDF via email every Friday evening. Sold as annual subscription with 48 issues per year. Subscribers include all of Japan's largest pharmaceutical and life sciences companies.

msapr.com
2Beikoku Bio Gyokai Geppo (US Bio Industry Monthly Report)
TypeSubscription Recurring
Description

Monthly report covering developments in the US biotech industry. Each issue includes feature articles, interviews, and sections on licensing, venture capital, M&A, IPOs, and stock market movements. Sold as annual subscription with 12 issues per year.

msapr.com
3Blue Moose Research (Customized Reports)
TypeProfessional Services
Description

Boutique research division providing customized reports on select topics. Reports cover US healthcare legislation, biosimilars, pharmaceutical distribution, and other timely topics. Created on client request basis.

msapr.com
4Consulting and Advisory Services
TypeProfessional Services
Description

Research and consulting services including gathering and analyzing information about US regulations, corporations, and industries. Also includes conducting interviews with key opinion leaders and facilitating B2B relationships for Japanese companies.

msapr.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Annual subscription to US Pharmaceutical Industry Weekly Report
ModelSubscriptionBilling cadenceAnnual
Notes

Annual contract with 48 issues per year. PDF delivered weekly via email every Friday evening (Eastern Time). Contact required for pricing.

msapr.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1Beikoku Seiyaku Gyokai Shuho (U.S. Pharmaceutical Industry Weekly Report)
Description

Weekly report covering regulatory and industry developments in the U.S. pharmaceutical market published in Japanese.

msapr.com
+2 more records
Core offering1 text field

MSA Partners publishes Japanese-language market intelligence on the US pharmaceutical and biotech industries and provides research, consulting, business-to-business facilitation, and communications support services to Japanese companies operating in or entering the US market. Its flagship offerings are the Beikoku Seiyaku Gyokai Shuho (US Pharmaceutical Industry Weekly Report) and the Beikoku Bio Gyokai Geppo (US Bio Industry Monthly Report), complemented by customized research via its Blue Moose Research division and consulting/advisory engagements.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Corporate subscribers include all of Japan's largest pharmaceutical and life sciences companies
Product overview1 text field

MSA Partners is a consulting and research services firm that operates a portfolio of Japanese-language publications and professional services for Japanese companies doing business in the U.S. The core offerings include two regular publications: the Beikoku Seiyaku Gyokai Shuho (U.S. Pharmaceutical Industry Weekly Report), a weekly publication covering FDA regulations and pharma/biotech industry news, and the Beikoku Bio Gyokai Geppo (U.S. Bio Industry Monthly Report), a monthly biotech industry digest. Supporting these publications is the Blue Moose Research division providing customized reports, alongside three service lines: B2B Facilitation Services (partner identification and market entry support), Research & Consulting Services (regulatory and industry analysis), and Communications Support Services (language bridge and training). The company also maintains a subscriber-only online archive system for accessing back issues of the weekly report.

Product and service6 records
1Beikoku Seiyaku Gyokai Shuho (U.S. Pharmaceutical Industry Weekly Report)
CategorySubscription Publication
Description

Weekly Japanese-language report covering regulatory and industry developments in the U.S. pharmaceutical market. Each issue includes a feature article, an interview article (with pharma/biotech executives, government officials, medical and legal experts), and news sections on regulatory, company, biotech, and research developments. Sold as an annual subscription (48 issues/year) to corporate subscribers including all of Japan's largest pharmaceutical and life sciences companies.

2Beikoku Bio Gyokai Geppo (U.S. Bio Industry Monthly Report)
CategorySubscription Publication
Description

Monthly Japanese-language report covering developments in the U.S. biotech industry. Each issue includes a feature article, an original interview, and four additional sections covering licensing, venture capital, mergers and acquisitions/IPOs/secondary offerings, and stock market movements. Sold as an annual subscription (12 issues/year) to Japan's largest pharmaceutical and other life sciences companies.

3Blue Moose Research (Customized Reports)
CategoryCustom Research Service
Description

Boutique research division at MSA providing customized reports on select topics on a client-request basis. Topics include US healthcare legislation, biosimilars, pharmaceutical distribution, and other timely issues. Tailored to specific client business needs.

4Business-to-Business Facilitation Services
CategoryConsulting Service
Description

Service helping Japanese companies in a variety of industries assess the US market, identify potential partner companies, and initiate relationships. Targets Japanese-headquartered organizations seeking US market entry or expansion support.

5Research & Consulting Services
CategoryConsulting Service
Description

Service gathering and analyzing information about US regulations, corporations, and industries, including conducting interviews with key opinion leaders (executives, researchers, government officials). Sold to Japanese companies needing in-depth US regulatory and industry analysis beyond the standard publications.

6Communications Support Services
CategoryConsulting Service
Description

Service supporting and enhancing communication flow between Japanese-speaking and English-speaking offices or departments at global companies by reducing the Japanese/English language barrier. Includes conducting seminars and Q&A sessions for employees and executives.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global market research and consulting firm with a dedicated pharma practice covering pipelines, deals, and regulatory trends. Overlaps with MSA's custom research and consulting offerings, though GlobalData is far broader and more enterprise-software-led.

TypeBroad incumbent
Description

Informa's pharma intelligence arm offering deep global coverage of drug development, regulatory, clinical trial, and deal data. Comparable to MSA as a subscription-based pharma intelligence provider, though at vastly larger scale and broader geographic scope.

TypeDirect peer
Description

Cross-border business development consultancy that helps Japanese and other Asian technology and life sciences companies expand into Western markets. Comparable to MSA's B2B Facilitation Services and Communications Support Services for Japanese pharma entering the US.

TypeBroad incumbent
Description

Global provider of pharma analytics, market intelligence, and commercial consulting. Touches MSA's territory through pharma market insights and Japan-US commercial advisory work, but at vastly larger scale with proprietary data assets.

TypeDirect peer
Description

Independent biotech industry intelligence and analysis publisher with weekly publications and custom research. Closely comparable to MSA's Beikoku publications in format (weekly features, deal coverage, executive interviews) and buyer profile (biopharma strategy teams).

6ZS Associates
TypeBroad incumbent
Description

Global management consulting firm with deep pharma and life sciences practice including commercial strategy and Japan market entry work. Overlaps with MSA's Research & Consulting and B2B Facilitation offerings for Japanese pharma clients.

7JETRO (Japan External Trade Organization)
TypeRegional player
Description

Japanese government-affiliated trade promotion organization supporting Japanese companies expanding overseas, including into the US. Partially overlaps with MSA's mission of helping Japanese companies succeed in the US, though JETRO is a non-profit public entity spanning all industries.

8Fierce Pharma
TypeEmerging player
Description

Pharma industry news and analysis outlet covering US drug development, regulatory, and commercial news. Comparable to the news-coverage portion of MSA's weekly publication, though distributed freely online rather than as a paid Japanese-language subscription.

TypeEmerging player
Description

Industry publications providing interviews, analysis, and country-level coverage of pharmaceutical markets including Japan-US cross-border activity. Partial overlap with MSA's executive interview content and bilingual market intelligence positioning.

TypeBroad incumbent
Description

Pharma and biotech commercial intelligence platform offering forecasts, deal data, and industry analysis. Comparable to MSA's monthly Beikoku Bio Geppo for licensing, venture capital, M&A, and IPO coverage of US biotech.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MSA Partners

Pharmaceutical Market Intelligence & Cross-Border Business Consultingmsapr.com

MSA Partners firmographics

Firmographics
Name
MSA Partners
Legal name
MSAPR Partners
Website
https://msapr.com
Company type
Private
Founded year
1983
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

MSA Partners industry classification

Industry
Product category
Pharmaceutical Market Intelligence & Cross-Border Business Consulting
NAICS
Marketing Research and Public Opinion Polling (541910), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYMPAAALAA
B2B / Industrial Market Research

Keywords

  • Pharmaceutical market intelligence
  • Biotech industry research
  • Cross-border consulting
  • Japanese business consulting
  • Regulatory intelligence services

Where MSA Partners is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

MSA Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Beikoku Seiyaku Gyokai Shuho (US Pharmaceutical Industry Weekly Report): Weekly publication covering regulatory and industry developments in the US pharmaceutical market, published in Japanese. Delivered as PDF via email every Friday evening. Sold as annual subscription with 48 issues per year. Subscribers include all of Japan's largest pharmaceutical and life sciences companies.
  2. Beikoku Bio Gyokai Geppo (US Bio Industry Monthly Report): Monthly report covering developments in the US biotech industry. Each issue includes feature articles, interviews, and sections on licensing, venture capital, M&A, IPOs, and stock market movements. Sold as annual subscription with 12 issues per year.
  3. Blue Moose Research (Customized Reports): Boutique research division providing customized reports on select topics. Reports cover US healthcare legislation, biosimilars, pharmaceutical distribution, and other timely topics. Created on client request basis.
  4. Consulting and Advisory Services: Research and consulting services including gathering and analyzing information about US regulations, corporations, and industries. Also includes conducting interviews with key opinion leaders and facilitating B2B relationships for Japanese companies.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualAnnual subscription to US Pharmaceutical Industry Weekly Report

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

MSA Partners product offering

Product offering

Core offering

MSA Partners publishes Japanese-language market intelligence on the US pharmaceutical and biotech industries and provides research, consulting, business-to-business facilitation, and communications support services to Japanese companies operating in or entering the US market. Its flagship offerings are the Beikoku Seiyaku Gyokai Shuho (US Pharmaceutical Industry Weekly Report) and the Beikoku Bio Gyokai Geppo (US Bio Industry Monthly Report), complemented by customized research via its Blue Moose Research division and consulting/advisory engagements.

Product overview

MSA Partners is a consulting and research services firm that operates a portfolio of Japanese-language publications and professional services for Japanese companies doing business in the U.S. The core offerings include two regular publications: the Beikoku Seiyaku Gyokai Shuho (U.S. Pharmaceutical Industry Weekly Report), a weekly publication covering FDA regulations and pharma/biotech industry news, and the Beikoku Bio Gyokai Geppo (U.S. Bio Industry Monthly Report), a monthly biotech industry digest. Supporting these publications is the Blue Moose Research division providing customized reports, alongside three service lines: B2B Facilitation Services (partner identification and market entry support), Research & Consulting Services (regulatory and industry analysis), and Communications Support Services (language bridge and training). The company also maintains a subscriber-only online archive system for accessing back issues of the weekly report.

Differentiator

Problem solved

Functional benefit

Brands

  • Beikoku Seiyaku Gyokai Shuho (U.S. Pharmaceutical Industry Weekly Report): Weekly report covering regulatory and industry developments in the U.S. pharmaceutical market published in Japanese.
  • Beikoku Bio Gyokai Geppo (U.S. Bio Industry Monthly Report)
  • Blue Moose Research

Products and services

  • Beikoku Seiyaku Gyokai Shuho (U.S. Pharmaceutical Industry Weekly Report) Weekly Japanese-language report covering regulatory and industry developments in the U.S. pharmaceutical market. Each issue includes a feature article, an interview article (with pharma/biotech executives, government officials, medical and legal experts), and news sections on regulatory, company, biotech, and research developments. Sold as an annual subscription (48 issues/year) to corporate subscribers including all of Japan's largest pharmaceutical and life sciences companies.
  • Beikoku Bio Gyokai Geppo (U.S. Bio Industry Monthly Report) Monthly Japanese-language report covering developments in the U.S. biotech industry. Each issue includes a feature article, an original interview, and four additional sections covering licensing, venture capital, mergers and acquisitions/IPOs/secondary offerings, and stock market movements. Sold as an annual subscription (12 issues/year) to Japan's largest pharmaceutical and other life sciences companies.
  • Blue Moose Research (Customized Reports) Boutique research division at MSA providing customized reports on select topics on a client-request basis. Topics include US healthcare legislation, biosimilars, pharmaceutical distribution, and other timely issues. Tailored to specific client business needs.
  • Business-to-Business Facilitation Services Service helping Japanese companies in a variety of industries assess the US market, identify potential partner companies, and initiate relationships. Targets Japanese-headquartered organizations seeking US market entry or expansion support.
  • Research & Consulting Services Service gathering and analyzing information about US regulations, corporations, and industries, including conducting interviews with key opinion leaders (executives, researchers, government officials). Sold to Japanese companies needing in-depth US regulatory and industry analysis beyond the standard publications.
  • Communications Support Services Service supporting and enhancing communication flow between Japanese-speaking and English-speaking offices or departments at global companies by reducing the Japanese/English language barrier. Includes conducting seminars and Q&A sessions for employees and executives.

Quantifiable outcome

  • Corporate subscribers include all of Japan's largest pharmaceutical and life sciences companies

Companies that use MSA Partners

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

MSA Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

MSA Partners partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves6 records

Expansion highlights3 records

MSA Partners competitors and assessment

Company assessment

Broad incumbents

  • GlobalData Pharmaceutical: Global market research and consulting firm with a dedicated pharma practice covering pipelines, deals, and regulatory trends. Overlaps with MSA's custom research and consulting offerings, though GlobalData is far broader and more enterprise-software-led.
  • Citeline (Informa Pharma Intelligence): Informa's pharma intelligence arm offering deep global coverage of drug development, regulatory, clinical trial, and deal data. Comparable to MSA as a subscription-based pharma intelligence provider, though at vastly larger scale and broader geographic scope.
  • IQVIA: Global provider of pharma analytics, market intelligence, and commercial consulting. Touches MSA's territory through pharma market insights and Japan-US commercial advisory work, but at vastly larger scale with proprietary data assets.
  • ZS Associates: Global management consulting firm with deep pharma and life sciences practice including commercial strategy and Japan market entry work. Overlaps with MSA's Research & Consulting and B2B Facilitation offerings for Japanese pharma clients.
  • Norstella (EvaluatePharma): Pharma and biotech commercial intelligence platform offering forecasts, deal data, and industry analysis. Comparable to MSA's monthly Beikoku Bio Geppo for licensing, venture capital, M&A, and IPO coverage of US biotech.

Direct peers

  • Intralink: Cross-border business development consultancy that helps Japanese and other Asian technology and life sciences companies expand into Western markets. Comparable to MSA's B2B Facilitation Services and Communications Support Services for Japanese pharma entering the US.
  • BioCentury: Independent biotech industry intelligence and analysis publisher with weekly publications and custom research. Closely comparable to MSA's Beikoku publications in format (weekly features, deal coverage, executive interviews) and buyer profile (biopharma strategy teams).

Regional players

  • JETRO (Japan External Trade Organization): Japanese government-affiliated trade promotion organization supporting Japanese companies expanding overseas, including into the US. Partially overlaps with MSA's mission of helping Japanese companies succeed in the US, though JETRO is a non-profit public entity spanning all industries.

Emerging players

  • Fierce Pharma: Pharma industry news and analysis outlet covering US drug development, regulatory, and commercial news. Comparable to the news-coverage portion of MSA's weekly publication, though distributed freely online rather than as a paid Japanese-language subscription.
  • Pharma Japan / PharmaBoardroom: Industry publications providing interviews, analysis, and country-level coverage of pharmaceutical markets including Japan-US cross-border activity. Partial overlap with MSA's executive interview content and bilingual market intelligence positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

MSA Partners social profiles

Digital presence

MSA Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MSA Partners leadership team

Management profile

Number of profiles

Profiles3 records

MSA Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MSA Partners M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MSA Partners

What does MSA Partners do?

MSA Partners publishes Japanese-language market intelligence on the US pharmaceutical and biotech industries and provides research, consulting, business-to-business facilitation, and communications support services to Japanese companies operating in or entering the US market. Its flagship offerings are the Beikoku Seiyaku Gyokai Shuho (US Pharmaceutical Industry Weekly Report) and the Beikoku Bio Gyokai Geppo (US Bio Industry Monthly Report), complemented by customized research via its Blue Moose Research division and consulting/advisory engagements.

Is MSA Partners a public or private company?

MSA Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was MSA Partners founded?

MSA Partners was founded in 1983. It employs 1 to 10 people.

Where is MSA Partners based?

MSA Partners is headquartered in New York, United States, in the North America region.

How does MSA Partners make money?

Four revenue lines are on record. Beikoku Seiyaku Gyokai Shuho (US Pharmaceutical Industry Weekly Report) is the primary driver. The others are beikoku Bio Gyokai Geppo (US Bio Industry Monthly Report), blue Moose Research (Customized Reports) and consulting and Advisory Services.

Who are MSA Partners's main competitors?

Broad incumbents on record are GlobalData Pharmaceutical, Citeline (Informa Pharma Intelligence), IQVIA, ZS Associates and Norstella (EvaluatePharma). Direct peers are Intralink and BioCentury. JETRO (Japan External Trade Organization) is listed as a regional player. Emerging players are Fierce Pharma and Pharma Japan / PharmaBoardroom.

Does MSA Partners have an API?

No public API is recorded for MSA Partners.

What industry is MSA Partners in?

MSA Partners's product category is Pharmaceutical Market Intelligence & Cross-Border Business Consulting. Its primary akta.pro industry code is MPAAALAA, B2B / Industrial Market Research. Its NAICS code is 541910 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales